Evgen Pharma's total assets for Q2 2023 were £7.57M, a decrease of -21.45% from the previous quarter. GB:TCF total liabilities were £434.00K for the fiscal quarter, a 5.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.